Skip to main content
SpringerLink
Log in

Beta-blocker therapy in unstable severe heart failure, evidence or experience?

  • Point of View
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Currently, no evidence exists on the effects of beta-receptor blocker (BRB) treatment in patients with unstable severe heart failure. When confronted with this specific patient category, clinical experience in our centre has consistently guided us to lower the dose or stop BRB therapy. To share this experience, we present three clinical case scenarios and discuss background literature motivating our approach in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Waagstein F, Hjalmarson A, Varnauskas E, et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022–36.

    Article  PubMed  CAS  Google Scholar 

  2. Swedberg K, Hjalmarson A, Waagstein F, et al. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. 1979;1:1374–6.

    Article  PubMed  CAS  Google Scholar 

  3. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9–13.

    Google Scholar 

  4. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol heart failure study group. N Engl J Med. 1996;334:1349–55.

    Article  PubMed  CAS  Google Scholar 

  5. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF study group. JAMA. 2000;283:1295–302.

    Article  PubMed  CAS  Google Scholar 

  6. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650–4.

    Article  PubMed  CAS  Google Scholar 

  7. Haeck ML, Hoogslag GE, Rodrigo SF, et al. Treatment options in end-stage heart failure: where to go from here? Neth Heart J. 2012;20:167–75.

    Google Scholar 

  8. Boerlage-van Dijk K, Meregalli PG, Planken RN, Koch KT, Baan J Jr. Percutaneous left ventricular partitioning device for chronic heart failure. Neth Heart J. 2012 Nov 1. doi:10.1007/s12471-012-0331-5

  9. Luttik ML, Brons M, Jaarsma T, et al. Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapy. Neth Heart J. 2012;20:307–12.

    Google Scholar 

  10. Kortekaas KA, Lindeman JH, Versteegh MI, Stijnen T, Dion RA, Klautz RJ. Preexisting heart failure is an underestimated risk factor in cardiac surgery. Neth Heart J. 2012;20:202–7.

    Google Scholar 

  11. van der Wall EE. Cardiac resynchronisation improves survival in mild heart failure! Neth Heart J. 2011;19:103–4.

    Google Scholar 

  12. Klöpping C, Kirkels JH, de Jonge N. Beta-blocking agents in congestive heart failure: for each heart failure patient? Neth Heart J. 2005;13:163–4.

    Google Scholar 

  13. Jondeau G, Neuder Y, Eicher JC, et al. B-CONVINCED: beta-blocker continuation vs. interruption in patients with congestive heart failure hospitalized for a decompensation episode. Eur Heart J. 2009;30:2186–92.

    Article  PubMed  CAS  Google Scholar 

  14. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248–54.

    Article  PubMed  CAS  Google Scholar 

  15. Beck-da-Silva L, de Bold A, Davies R, et al. Effect of bisoprolol on right ventricular function and brain natriuretic peptide in patients with heart failure. Congest Heart Fail. 2004;10:127–32.

    Article  PubMed  CAS  Google Scholar 

  16. Tatli E, Kurum T, Aktoz M, et al. Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure. Int J Cardiol. 2008;125:273–6.

    Article  PubMed  Google Scholar 

  17. Desai RV, Guichard JL, Mujib M et al. Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving beta-blockers: Insights from the BEST trial. Int J Cardiol 2011;Ahead of print.

  18. Metra M, Nodari S, D'Aloia A, et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol. 2002;40:1248–58.

    Article  PubMed  CAS  Google Scholar 

  19. Bollano E, Tang MS, Hjalmarson A, et al. Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart. 2003;89:621–4.

    Article  PubMed  CAS  Google Scholar 

  20. Jennings DL, Thompson ML. Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure. Ann Pharmacother. 2009;43:1872–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Utrecht Medical Centre, Utrecht, the Netherlands

    C. L. Meuwese, J. H. Kirkels, N. de Jonge, H. M. Nathoe, P. A. Doevendans & C. Klöpping

Authors
  1. C. L. Meuwese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. H. Kirkels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. de Jonge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. M. Nathoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. A. Doevendans
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Klöpping
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Klöpping.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meuwese, C.L., Kirkels, J.H., de Jonge, N. et al. Beta-blocker therapy in unstable severe heart failure, evidence or experience?. Neth Heart J 21, 3–5 (2013). https://doi.org/10.1007/s12471-012-0366-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12471-012-0366-7

Keywords

Search

Navigation